Structure Therapeutics (GPCR) Ownership - Who owns Structure Therapeutics?
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GPCR showed earnings on August 06, 2025. You can read more about the earnings report here.